Oral cancer remains a significant public health concern globally, with smoking identified as a primary risk factor. This abstract reviews the role of smoking in the etiology of oral cancer, emphasizing its contribution to carcinogenesis through the induction of genetic mutations, oxidative stress, and inflammation. Tobacco smoke contains carcinogenic compounds such as polycyclic aromatic hydrocarbons, nitrosamines, and heavy metals, which are implicated in the transformation of oral mucosal cells. Epidemiological studies consistently demonstrate a dose-response relationship between smoking intensity and oral cancer risk. Despite advances in prevention and treatment, smoking cessation remains a critical component in reducing oral cancer incidence. This review underscores the importance of public health initiatives and targeted interventions aimed at mitigating smoking-related oral cancer risk.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11888633 | PMC |
http://dx.doi.org/10.4103/jpbs.jpbs_1305_24 | DOI Listing |
Braz J Biol
March 2025
Centro Universitário CESMAC, Maceió, AL, Brasil.
Adenoid Cystic Carcinoma - ACC is a common neoplasm in major and minor salivary glands with a high risk of metastasis. Thus, the objective of the present study was to perform an analysis to better understand the histological grading systems of the ACC and its influence on tumor prognosis in terms of overall survival, disease-free and metastasis-free. This is a systematic review, with meta-analysis, based on the PRISMA parameters.
View Article and Find Full Text PDFJ Cancer Educ
March 2025
Département d´Odontologie, Faculté de Santé, Service d´Odontologie, Centre HospitalierUniversitaire, Université de Toulouse, 3 chemin des Maraîchers, Toulouse, 31400, France.
A patient who had undergone radiation therapy for cancer developed a white coating on their tongue. This was initially misdiagnosed as a fungal infection, leading to unnecessary treatment. The actual cause was dry mouth, a common side effect of radiation therapy.
View Article and Find Full Text PDFArch Dermatol Res
March 2025
Department of Dermatology, MD Anderson Cancer Center, Houston, TX, USA.
Aging Dis
February 2025
Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Nanozymes, which are nanomaterials that replicate the catalytic activities of natural enzymes in biological systems, have recently demonstrated considerable potential in improving cancer immunotherapy by altering the tumor microenvironment. Nanozyme-driven immune responses represent an innovative therapeutic modality with high effectiveness and minimal side effects. These nanozymes activate the immune system to specifically recognize and destroy cancer cells.
View Article and Find Full Text PDFInt J Cancer
March 2025
Center for Epigenetics & Disease Prevention, Texas A&M HEALTH, and Department of Translational Medical Sciences, Texas A&M University Naresh K. Vashisht College of Medicine, Houston, Texas, USA.
A previously reported clinical trial in familial adenomatous polyposis (FAP) patients treated with erlotinib plus sulindac (ERL + SUL) highlighted immune response/interferon-γ signaling as a key pathway. In this study, we combine intermittent low-dose ERL ± SUL treatment in the polyposis in rat colon (Pirc) model with mechanistic studies on tumor-associated immune modulation. At clinically relevant doses, short-term (16 weeks) and long-term (46 weeks) ERL ± SUL administration results in near-complete tumor suppression in Pirc colon and duodenum (p < 0.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!